| pubmed-article:9821162 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9821162 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:9821162 | lifeskim:mentions | umls-concept:C0001811 | lld:lifeskim |
| pubmed-article:9821162 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:9821162 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:9821162 | lifeskim:mentions | umls-concept:C0002085 | lld:lifeskim |
| pubmed-article:9821162 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
| pubmed-article:9821162 | lifeskim:mentions | umls-concept:C0247001 | lld:lifeskim |
| pubmed-article:9821162 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:9821162 | pubmed:dateCreated | 1999-1-28 | lld:pubmed |
| pubmed-article:9821162 | pubmed:abstractText | This report examines plasma amyloid beta proteins A beta 40 and A beta 42 and apolipoprotein E (apoE) levels and their relationships with age in non-demented older adults with (N = 32) or without the apoE-epsilon 4 allele (N = 94). A beta levels did not differ between the groups whereas the epsilon 4 allele was associated with a significant reduction in plasma apoE. In subjects with the epsilon 4 allele, increasing age was associated with significant reduction in plasma A beta 40. Subjects without the epsilon 4 allele showed a significant positive correlation between A beta 40 and A beta 42 levels. There was also a significant correlation between plasma A beta 40 and apoE levels in all subjects. | lld:pubmed |
| pubmed-article:9821162 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9821162 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9821162 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9821162 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9821162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9821162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9821162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9821162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9821162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9821162 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9821162 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9821162 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:9821162 | pubmed:issn | 0364-3190 | lld:pubmed |
| pubmed-article:9821162 | pubmed:author | pubmed-author:ShawJJ | lld:pubmed |
| pubmed-article:9821162 | pubmed:author | pubmed-author:MehtaP DPD | lld:pubmed |
| pubmed-article:9821162 | pubmed:author | pubmed-author:WisniewskiTT | lld:pubmed |
| pubmed-article:9821162 | pubmed:author | pubmed-author:PomaraNN | lld:pubmed |
| pubmed-article:9821162 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9821162 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:9821162 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9821162 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9821162 | pubmed:pagination | 1563-6 | lld:pubmed |
| pubmed-article:9821162 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:9821162 | pubmed:meshHeading | pubmed-meshheading:9821162-... | lld:pubmed |
| pubmed-article:9821162 | pubmed:meshHeading | pubmed-meshheading:9821162-... | lld:pubmed |
| pubmed-article:9821162 | pubmed:meshHeading | pubmed-meshheading:9821162-... | lld:pubmed |
| pubmed-article:9821162 | pubmed:meshHeading | pubmed-meshheading:9821162-... | lld:pubmed |
| pubmed-article:9821162 | pubmed:meshHeading | pubmed-meshheading:9821162-... | lld:pubmed |
| pubmed-article:9821162 | pubmed:meshHeading | pubmed-meshheading:9821162-... | lld:pubmed |
| pubmed-article:9821162 | pubmed:meshHeading | pubmed-meshheading:9821162-... | lld:pubmed |
| pubmed-article:9821162 | pubmed:meshHeading | pubmed-meshheading:9821162-... | lld:pubmed |
| pubmed-article:9821162 | pubmed:meshHeading | pubmed-meshheading:9821162-... | lld:pubmed |
| pubmed-article:9821162 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9821162 | pubmed:articleTitle | Decreases in plasma A beta 1-40 levels with aging in non-demented elderly with ApoE-epsilon 4 allele. | lld:pubmed |
| pubmed-article:9821162 | pubmed:affiliation | Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA. POMARA@nki.rfmh.org | lld:pubmed |
| pubmed-article:9821162 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9821162 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
